BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3090975)

  • 1. [Antiaggregatory and anticoagulant actions of oligoamines. 1. 4-Piperidinylmethaneamines].
    Rehse K; Werner U
    Arch Pharm (Weinheim); 1986 Jun; 319(6):505-15. PubMed ID: 3090975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiaggregatory and anticoagulant effects of oligoamines. 5. Alicyclic di- and triamines].
    Rehse K; Carstensen A; Ernst HJ
    Arch Pharm (Weinheim); 1987 Sep; 320(9):829-36. PubMed ID: 3675171
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-aggregation and anticoagulant effects of oligoamines. 3. M-phenylenebisaminoalkanes].
    Rehse K; Lükens U; Leissring S; Claus G
    Arch Pharm (Weinheim); 1987 Mar; 320(3):228-33. PubMed ID: 3579524
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-aggregant and anticoagulant effects of oligoamines. II. P-phenylenebis(alkanamines)].
    Rehse K; Lükens U
    Arch Pharm (Weinheim); 1986 Jul; 319(7):603-7. PubMed ID: 3767617
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiaggregatory and anticoagulant effects of oligoamines. 7. Benzene-1,3,5-trialkaneamines].
    Rehse K; Lükens U; Claus G
    Arch Pharm (Weinheim); 1987 Dec; 320(12):1233-8. PubMed ID: 3439865
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulation of 12-HETE production in human platelets by an immunomodulator, LF 1695. Evidence for activation of arachidonate liberation coupled to cyclo-oxygenase inhibition.
    Hullin F; Ragab-Thomas JM; Sepulchre C; Pascal M; Chap H; Douste-Blazy L
    Biochem Pharmacol; 1989 Sep; 38(17):2763-72. PubMed ID: 2505775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiaggregatory and anticoagulant effects of oligoamines. 12. Alkyl- and arylalkyl- derivatives of putrescine, spermidine and spermine].
    Rehse K; Puchert E; Leissring S
    Arch Pharm (Weinheim); 1990 May; 323(5):287-94. PubMed ID: 2383171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of octadecatrienoic acid on human platelet function.
    Takenaga M; Hirai A; Terano T; Tamura Y; Kitagawa H; Yoshida S
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():418-22. PubMed ID: 2889336
    [No Abstract]   [Full Text] [Related]  

  • 9. Arachidonic acid peroxidation, prostaglandin synthesis and platelet function.
    Rao GH; Gerrard JM; Eaton JW; White JG
    Photochem Photobiol; 1978; 28(4-5):845-50. PubMed ID: 733933
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
    Lagarde M; Guichardant M; Ghazi I; Dechavanne M
    Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G; Block HU; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ; Chang LF; McSpadden MM; Yang D
    Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
    [No Abstract]   [Full Text] [Related]  

  • 13. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
    Blackwell GJ; Duncombe WG; Flower RJ; Parsons MF; Vane JR
    Br J Pharmacol; 1977 Feb; 59(2):353-66. PubMed ID: 837023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet arachidonic acid metabolism in diabetes mellitus.
    Halushka PV; Mayfield R; Wohltmann HJ; Rogers RC; Goldberg AK; McCoy SA; Loadholt CB; Colwell JA
    Diabetes; 1981; 30(Suppl 2):44-8. PubMed ID: 6795072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effects of local anaesthetics on platelet aggregation.
    Gilani AH; Saeed SA
    Biochem Soc Trans; 1990 Apr; 18(2):288-9. PubMed ID: 2116336
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiaggregatory and anticoagulant effects of oligoamines. 10. Tertiary oligoamines and quaternary ammonium salts].
    Rehse K; Kämpfe M
    Arch Pharm (Weinheim); 1989 Nov; 322(11):811-5. PubMed ID: 2624527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
    Chignard M; Vargaftig BB
    Biochem Pharmacol; 1978; 27(11):1603-6. PubMed ID: 29642
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced incorporation of exogenous arachidonic acid into phosphatidylinositol and other phospholipids during the early stages of thrombin-induced aggregation in gerbil platelets.
    Agwu DE; Johnstone I; Crane S; Holub BJ
    Lipids; 1983 Dec; 18(12):859-62. PubMed ID: 6420635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-aggregatory and anticoagulant properties of oligoamines. 11. Oligoamines with two primary amine groups].
    Rehse K; Rose B; Leissring S
    Arch Pharm (Weinheim); 1990 Feb; 323(2):103-8. PubMed ID: 2334273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet ADP and serotonin release by carbon monoxide and in cigarette smokers.
    Mansouri A; Perry CA
    Experientia; 1984 May; 40(5):515-7. PubMed ID: 6427001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.